David N. Hunter
3Patents
1h-index
38Co-inventors
40Inventor score
Filing activity: Jan 16, 2015 → Aug 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9708336B2 | Metallo-beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10227331B2 | Metallo-β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11648250B2 | Tetrahydroquinazoline derivatives as selective cytotoxic agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.